Please wait a minute...
J Zhejiang Univ (Med Sci)  2020, Vol. 49 Issue (5): 644-650    DOI: 10.3785/j.issn.1008-9292.2020.07.03
    
Research progress on etiologic diagnosis of ocular viral diseases
DUAN Runping(),XU Yesheng,ZHENG Libin,YAO Yufeng*()
Department of Ophthalmology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China
Download: HTML( 13 )   PDF(1073KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

A large number of viruses have been found to be associated with ocular diseases, including human adenovirus, human herpesvirus (HHV), human T lymphotropic virus type-1 (HTLV-1), and newly emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This group of diseases is prone to be misdiagnosed or missed diagnosis, resulting in serious tissue and visual damage. Etiological diagnosis is a powerful auxiliary mean to diagnose the ocular diseases associated with human adenovirus, herpes simplex virus 1 and varicella-zoster virus, and it provides the leading diagnosis evidence of infections with herpes simplex virus 2, Epstein-Barr virus, cytomegalovirus, HHV-6/7, HHV-8, HTLV-1 and SARS-CoV-2. Virus isolation, immunoassay and genetic diagnosis are usually used for etiologic diagnosis. For genetic diagnosis, the PCR technique is the most important approach because of its advantages of rapid detection, convenient operation, high sensitivity and high specificity.



Key wordsViral diseases      Ocular diseases      Epidemiology      Etiologic diagnosis      Polymerase chain reaction      Review     
Received: 03 February 2020      Published: 19 November 2020
CLC:  R77  
  R511  
Corresponding Authors: YAO Yufeng     E-mail: ophthaldrp@zju.edu.cn;yaoyf@zju.edu.cn
Cite this article:

DUAN Runping,XU Yesheng,ZHENG Libin,YAO Yufeng. Research progress on etiologic diagnosis of ocular viral diseases. J Zhejiang Univ (Med Sci), 2020, 49(5): 644-650.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2020.07.03     OR     http://www.zjujournals.com/med/Y2020/V49/I5/644


病毒感染性眼病病原学诊断的研究进展

多种病毒可导致眼部疾病,包括腺病毒、人类疱疹病毒、人类T淋巴细胞白血病病毒1型(HTLV-1)及新发现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)等。这类疾病的鉴别诊断较困难,容易被误诊和漏诊,导致严重的组织损伤和视觉损伤。腺病毒、单纯疱疹病毒1型和水痘-带状疱疹病毒相关眼病的诊断中,病原学诊断可作为一种强有力的辅助诊断工具;而在单纯疱疹病毒2型、巨细胞病毒、EB病毒、人类疱疹病毒6型和7型、人类疱疹病毒8型、HTLV-1和SARS-CoV-2相关眼病的诊断中,病原学诊断则发挥着主导作用。病毒培养、免疫组织化学或免疫荧光法及以PCR为代表的病毒基因诊断法是三种主要的病原检测手段,其中PCR技术检测快速、操作便捷、敏感度和特异度高,成为眼科病毒学诊断中最重要的工具。


关键词: 病毒性疾病,  眼部疾病,  流行病学,  病原学诊断,  聚合酶链反应,  综述 
病毒名称 眼部疾病 病原学诊断方法 参考文献序号
腺病毒 角结膜炎、咽结膜热 病毒分离培养、免疫荧光、PCR 12
人类疱疹病毒
  单纯疱疹病毒1型 角膜炎、葡萄膜炎、视网膜炎 病毒分离培养、免疫荧光、PCR 4, 26
  单纯疱疹病毒2型 急性视网膜坏死、葡萄膜炎 PCR 29-30
  水痘-带状疱疹病毒 角膜炎、葡萄膜炎、急性视网膜坏死 病毒分离培养、PCR 20
  EB病毒 结膜良性肿瘤、葡萄膜炎、视网膜炎 PCR 31, 39
  巨细胞病毒 视网膜炎、角膜内皮炎、葡萄膜炎 PCR 6, 22, 28
  人类疱疹病毒6型 角膜炎、葡萄膜炎 PCR 32, 40
  人类疱疹病毒7型 角膜内皮炎、眼部附属器淋巴瘤 PCR 41-42
  人类疱疹病毒8型 结膜卡波西肉瘤、葡萄膜炎 PCR 33, 43
人类T淋巴细胞白血病病毒1型 葡萄膜炎、角结膜干燥征、角膜炎 PCR 5
严重急性呼吸综合征冠状病毒2 结膜炎 PCR 8
Tab 1 Ocular diseases associated with 11 kinds of viruses and their etiologic diagnoses
[1]   TULLO A B , HIGGINS P G . Epidemic adenovirus keratoconjunctivitis[J]. Lancet (London, England), 1978, 1 442- 443
doi: 10.1016/S0140-6736(78)91229-1
[2]   ROWE A M , ST LEGER A J , JEON S et al. Herpes keratitis[J]. Prog Retin Eye Res, 2013, 32 88- 101
doi: 10.1016/j.preteyeres.2012.08.002
[3]   PATHANAPITOON K , TESAVIBUL N , CHOOPONG P et al. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection[J]. JAMA Ophthalmol, 2013, 131 (5): 638- 645
doi: 10.1001/jamaophthalmol.2013.2860
[4]   WALTERS G , JAMES T E . Viral causes of the acute retinal necrosis syndrome[J]. Curr Opin Ophthalmol, 2001, 12 (3): 191- 195
doi: 10.1097/00055735-200106000-00008
[5]   TERADA Y , KAMOI K , KOMIZO T et al. Human T cell leukemia virus type 1 and eye diseases[J]. J Ocul Pharmacol Ther, 2017, 33 (4): 216- 223
doi: 10.1089/jop.2016.0124
[6]   KOIZUMI N , INATOMI T , SUZUKI T et al. Clinical features and management of cytomegalovirus corneal endotheliitis:analysis of 106 cases from the Japan corneal endotheliitis study[J]. Br J Ophthalmol, 2015, 99 (1): 54- 58
doi: 10.1136/bjophthalmol-2013-304625
[7]   SUGITA S , OGAWA M , SHIMIZU N et al. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases[J]. Ophthalmology, 2013, 120 (9): 1761- 1768
doi: 10.1016/j.ophtha.2013.02.020
[8]   周翔天, 瞿佳 . 新型冠状病毒与眼, 我们所知道的与我们应该做的[J]. 中华眼视光学与视觉科学杂志, 2020, 22 (4): 241- 246
ZHOU Xiangtian , QU Jia . 2019-nCoV and eye, what we know and what we should do[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2020, 22 (4): 241- 246
doi: 10.3760/cma.j.cn115909-20200213-00035
[9]   RADKE J R , COOK J L . Human adenovirus infections:update and consideration of mechanisms of viral persistence[J]. Curr Opin Infect Dis, 2018, 31 (3): 251- 256
doi: 10.1097/QCO.0000000000000451
[10]   KANEKO H , SUZUTANI T , AOKI K et al. Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan[J]. Br J Ophthalmol, 2011, 95 (1): 32- 36
doi: 10.1136/bjo.2009.178772
[11]   UDEH B L , SCHNEIDER J E , OHSFELDT R L . Cost effectiveness of a point-of-care test for adenoviral conjunctivitis[J]. Am J Med Sci, 2008, 336 (3): 254- 264
doi: 10.1097/MAJ.0b013e3181637417
[12]   JHANJI V , CHAN T C , LI E Y et al. Adenoviral keratoconjunctivitis[J]. Surv Ophthalmol, 2015, 60 (5): 435- 443
doi: 10.1016/j.survophthal.2015.04.001
[13]   EL-SAYED ZAKI M , ABD-EL FATAH G A . Rapid detection of oculopathogenic adenovirus in conjunctivitis[J]. Curr Microbiol, 2008, 56 (2): 105- 109
doi: 10.1007/s00284-007-9054-z
[14]   KOIDL C , BOZIC M , MOSSB?CK G et al. Rapid diagnosis of adenoviral keratoconjunctivitis by a fully automated molecular assay[J]. Ophthalmology, 2005, 112 (9): 1521- 1528
doi: 10.1016/j.ophtha.2005.04.011
[15]   BRADLEY H , MARKOWITZ L E , GIBSON T et al. Seroprevalence of herpes simplex virus types 1 and 2——United States, 1999-2010[J]. J Infect Dis, 2014, 209 (3): 325- 333
doi: 10.1093/infdis/jit458
[16]   TSATSOS M , MACGREGOR C , ATHANASIADIS I et al. Herpes simplex virus keratitis:an update of the pathogenesis and current treatment with oral and topical antiviral agents[J]. Clin Exp Ophthalmol, 2016, 44 (9): 824- 837
doi: 10.1111/ceo.12785
[17]   YOUNG R C , HODGE D O , LIESEGANG T J et al. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007:the effect of oral antiviral prophylaxis[J]. Arch Ophthalmol, 2010, 128 (9): 1178- 1183
doi: 10.1001/archophthalmol.2010.187
[18]   LOOKER K J , GARNETT G P , SCHMID G P . An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection[J]. Bull World Health Organ, 2008, 86 (10): 805- 812, A
doi: 10.2471/blt.07.046128
[19]   OXMAN M N , LEVIN M J , JOHNSON G R et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults[J]. N Engl J Med, 2005, 352 (22): 2271- 2284
doi: 10.1056/NEJMoa051016
[20]   LIESEGANG T J . Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity[J]. Ophthalmology, 2008, 115 (2 Suppl): S3- S12
doi: 10.1016/j.ophtha.2007.10.009
[21]   COHEN J I . Epstein-Barr virus infection[J]. N Engl J Med, 2000, 343 (7): 481- 492
doi: 10.1056/NEJM200008173430707
[22]   CHAN N S , CHEE S P , CASPERS L et al. Clinical features of CMV-associated anterior uveitis[J]. Ocul Immunol Inflamm, 2018, 26 (1): 107- 115
doi: 10.1080/09273948.2017.1394471
[23]   AGUT H , BONNAFOUS P , GAUTHERET-DEJEAN A . Update on infections with human herpesviruses 6A, 6B, and 7[J]. Med Mal Infect, 2017, 47 (2): 83- 91
doi: 10.1016/j.medmal.2016.09.004
[24]   AGUT H , BONNAFOUS P , GAUTHERET-DEJEAN A . Human herpesviruses 6A, 6B, and 7[J]. Microbiol Spectr, 2016, 4 (3):
doi: 10.1128/microbiolspec.DMIH2-0007-2015
[25]   AUTEN M , KIM A S , BRADLEY K T et al. Human herpesvirus 8-related diseases:histopathologic diagnosis and disease mechanisms[J]. Semin Diagn Pathol, 2017, 34 (4): 371- 376
doi: 10.1053/j.semdp.2017.04.004
[26]   LIESEGANG T J . Herpes simplex virus epidemiology and ocular importance[J]. Cornea, 2001, 20 (1): 1- 13
doi: 10.1097/00003226-200101000-00001
[27]   SZETO S K , CHAN T C , WONG R L et al. Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus[J]. Cornea, 2017, 36 (3): 338- 342
doi: 10.1097/ICO.0000000000001046
[28]   PORT A D , ORLIN A , KISS S et al. Cytomegalovirus retinitis:a review[J]. J Ocul Pharmacol Ther, 2017, 33 (4): 224- 234
doi: 10.1089/jop.2016.0140
[29]   SUGITA S , SHIMIZU N , WATANABE K et al. Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis[J]. Br J Ophthalmol, 2008, 92 (7): 928- 932
doi: 10.1136/bjo.2007.133967
[30]   GROSE C . Acute retinal necrosis caused by herpes simplex virus type 2 in children:reactivation of an undiagnosed latent neonatal herpes infection[J]. Semin Pediatr Neurol, 2012, 19 (3): 115- 118
doi: 10.1016/j.spen.2012.02.005
[31]   SATO T, KITAMURA R, KABURAKI T, et al. Retinitis associated with double infection of Epstein-Barr virus and varicella-zoster virus: A case report[J/OL]. Medicine (Baltimore), 2018, 97(31): e11663. DOI: 10.1097/MD.0000000000011663.
[32]   OGATA N , KOIKE N , YOSHIKAWA T et al. Human herpesvirus 6-associated uveitis with optic neuritis diagnosed by multiplex PCR[J]. Jpn J Ophthalmol, 2011, 55 (5): 502- 505
doi: 10.1007/s10384-011-0069-4
[33]   MINODA H , USUI N , SATA T et al. Human herpesvirus-8 in Kaposi's sarcoma of the conjunctiva in a patient with AIDS[J]. Jpn J Ophthalmol, 2006, 50 (1): 7- 11
doi: 10.1007/s10384-005-0268-y
[34]   BISPO P , DAVOUDI S , SAHM M L et al. Rapid detection and identification of uveitis pathogens by qualitative multiplex real-time PCR[J]. Invest Ophthalmol Vis Sci, 2018, 59 (1): 582- 589
doi: 10.1167/iovs.17-22597
[35]   PRAMOD N P , THYAGARAJAN S P , MOHAN K V et al. Polymerase chain reaction in the diagnosis of herpetic keratitis:experience in a developing country[J]. Can J Ophthalmol, 2000, 35 (3): 134- 140
doi: 10.1016/s0008-4182(00)80006-x
[36]   YAMAMOTO S , SHIMOMURA Y , KINOSHITA S et al. Detection of herpes simplex virus DNA in human tear film by the polymerase chain reaction[J]. Am J Ophthalmol, 1994, 117 (2): 160- 163
doi: 10.1016/s0002-9394(14)73071-5
[37]   CULBERTSON W W , BLUMENKRANZ M S , J S PEPOSE J S et al. Varicella zoster virus is a cause of the acute retinal necrosis syndrome[J]. Ophthalmology, 1986, 93 (5): 559- 569
doi: 10.1016/s0161-6420(86)33701-1
[38]   MIYAZAKI D , SHIMIZU D , SHIMIZU Y et al. Diagnostic efficacy of real-time PCR for ocular cytomegalovirus infections[J]. Graefes Arch Clin Exp Ophthalmol, 2018, 256 (12): 2413- 2420
doi: 10.1007/s00417-018-4111-9
[39]   DAIBATA M , KOMATSU T , TAGUCHI H . Human herpesviruses in primary ocular lymphoma[J]. Leuk Lymphoma, 2000, 37 (3-4): 361- 365
doi: 10.3109/10428190009089436
[40]   BOTO-DE-LOS-BUEIS A, ROMERO GÓMEZ M P, DEL HIERRO ZARZUELO A, et al. Recurrent ocular surface inflammation associated with human herpesvirus 6 infection[J/OL]. Eye Contact Lens, 2015, 41(3): e11-e13. DOI: 10.1097/ICL.0b013e3182a70a1b.
[41]   INOUE T , KANDORI M , TAKAMATSU F et al. Corneal endotheliitis with quantitative polymerase chain reaction positive for human herpesvirus 7[J]. Arch Ophthalmol, 2010, 128 (4): 502- 503
doi: 10.1001/archophthalmol.2010.35
[42]   USUI Y , RAO N A , TAKASE H et al. Comprehensive polymerase chain reaction assay for detection of pathogenic DNA in lymphoproliferative disorders of the ocular adnexa[J]. Sci Rep, 2016, 6 36621
doi: 10.1038/srep36621
[43]   BRASNU E , WECHSLER B , BRON A et al. Efficacy of interferon-alpha for the treatment of Kaposi's sarcoma herpesvirus-associated uveitis[J]. Am J Ophthalmol, 2005, 140 (4): 746- 748
doi: 10.1016/j.ajo.2005.04.025
[44]   UCHIMARU K , NAKAMURA Y , TOJO A et al. Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area[J]. Int J Hematol, 2008, 88 (5): 565- 570
doi: 10.1007/s12185-008-0209-x
[45]   WATANABE T . Current status of HTLV-1 infection[J]. Int J Hematol, 2011, 94 (5): 430- 434
doi: 10.1007/s12185-011-0934-4
[46]   王惠榕, 严延生, 张秋文 et al. 福建东部沿海地区人类嗜T淋巴细胞白血病病毒Ⅰ/Ⅱ感染的血清流行病学研究[J]. 中华流行病学杂志, 2004, 25 (5): 428- 430
WANG Huirong , YAN Yansheng , ZHANG Qiuwen et al. Sero-epidemiological study on the human T-cell leukaemia virus type Ⅰ/Ⅱ infection in the east coastal areas of Fujian province[J]. Chinese Journal of Epidemiology, 2004, 25 (5): 428- 430
[47]   The T- and B-cell malignancy Study Group: The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan--estimates of risk of ATL and its geographical and clinical features[J]. Gan No Rinsho, 1990, Spec No: 431-441.
[48]   MOCHIZUKI M , WATANABE T , YAMAGUCHI K et al. Uveitis associated with human T lymphotropic virus type I:seroepidemiologic, clinical, and virologic studies[J]. J Infect Dis, 1992, 166 (4): 943- 944
doi: 10.1093/infdis/166.4.943
[49]   ONO A , MOCHIZUKI M , YAMAGUCHI K et al. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids[J]. Invest Ophthalmol Vis Sci, 1997, 38 (3): 676- 689
[50]   SAGAWA K , MOCHIZUKI M , MASUOKA K et al. Immunopathological mechanisms of human T cell lymphotropic virus type 1(HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production[J]. J Clin Invest, 1995, 95 (2): 852- 858
doi: 10.1172/JCI117735
[51]   李雪杰, 汪明, 陈长征 et al. 伴发或首发病毒性结膜炎的新型冠状病毒感染下眼科医师的防控策略[J]. 中华实验眼科杂志, 2020, 38 (3): 276- 280
LI Xuejie , WANG Ming , CHEN Changzheng et al. Ophthalmologists' strategy for the prevention and control of coronavirus pneumonia with conjunctivitis or with conjunctivitis as the first symptom[J]. Chinese Journal of Experimental Ophthalmology, 2020, 38 (3): 276- 280
doi: 10.3760/cma.j.issn.2095-0160.2020.0002
[52]   XIA J , TONG J , LIU M et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection[J]. J Med Virol, 2020, 92 (6): 589- 594
doi: 10.1002/jmv.25725
[53]   徐凯进, 蔡洪流, 沈毅弘 et al. 2019冠状病毒病(COVID-19)诊疗浙江经验[J]. 浙江大学学报(医学版), 2020, 49 (2): 147- 157
XU Kaijin , CAI Hongliu , SHEN Yihong et al. Management of COVID-19:the Zhejiang experience[J]. Journal of Zhejiang University (Medical Sciences), 2020, 49 (2): 147- 157
doi: 10.3785/j.issn.1008-9292.2020.02.02
[54]   LU R , ZHAO X , LI J et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J]. Lancet, 2020, 395 (10224): 565- 574
doi: 10.1016/S0140-6736(20)30251-8
[55]   孙琰, 潘欣, 柳林 et al. SARS-CoVS蛋白功能性受体ACE2在人、兔角膜、结膜中的表达[J]. 眼科新进展, 2004, 24 (5): 332- 336
SUN Yan , PAN Xin , LIU Lin et al. Expression of SARS coronavirus S protein functional receptor ACE2 in human and rabbit cornea and conjunctiva[J]. Recent Advances in Ophthalmology, 2004, 24 (5): 332- 336
doi: 10.3969/j.issn.1003-5141.2004.05.002
[1] LI Mengyao,LIU Pan,KE Yuehai,ZHANG Xue. Research progress on macrophage in radiation induced lung injury[J]. J Zhejiang Univ (Med Sci), 2020, 49(5): 623-628.
[2] HAN Xue,JIANG Guojun,SHI Qiaojuan. Effects of antihyperglycemics on endothelial progenitor cells[J]. J Zhejiang Univ (Med Sci), 2020, 49(5): 629-636.
[3] WU Wei,XU Jian. Research progress on the role of pentraxin 3 in polycystic ovary syndrome[J]. J Zhejiang Univ (Med Sci), 2020, 49(5): 637-643.
[4] JIANG Peiran,WANG Zhiping. Progress on axon regeneration in model organisms[J]. J Zhejiang Univ (Med Sci), 2020, 49(4): 500-507.
[5] XU Qinglin,LOU Guodong,WANG Tiantian,ZHANG Lisan. Advances in treatment of narcolepsy[J]. J Zhejiang Univ (Med Sci), 2020, 49(4): 419-424.
[6] SHEN Lihua,HUANG Fei,CHEN Xiang,XIONG Zuan,YANG Xiaoyu,LI Hui,CHENG Feng,GUO Jian,GONG Guofu. Diagnostic efficacy of three test kits for SARS-CoV-2 nucleic acid detection[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 185-190.
[7] YU Qing, XIONG Xiufang, SUN Yi. Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 1-19.
[8] DUAN Lingyan,YIN Xiangju,MENG Hong'en,FANG Xuexian,MIN Junxia,WANG Fudi. Progress on epigenetic regulation of iron homeostasis[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 58-70.
[9] LI Ai,ZHANG Tianyuan,GAO Jianqing. Progress on utilizing mesenchymal stem cells as cellular delivery system for targeting delivery of as drug/gene for anti-tumor therapy[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 20-34.
[10] HUANG Yaoping,YANG Feng,ZHOU Tianhua,XIE Shanshan. Emerging roles of Hippo signaling pathway in gastrointestinal cancers and its molecular mechanisms[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 35-43.
[11] ZHONG Wen,LOU Yan,QIU Chenyang,LI Donglin,ZHANG Hongkun. Antithrombotic therapy after iliac vein stenting[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 131-136.
[12] XU Yiming,YING Kejing. Research progress on neutrophil extracellular traps in tumor[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 107-112.
[13] LIU Xiaoxiao,GUO Liqiong,LIANG Cheng. Research progress on electroencephalogram characteristics of anti-N-methyl-D-aspartate receptor encephalitis[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 118-123.
[14] FANG Juan,PAN Zhicheng,GUO Xiaogang. Research advance of ANRIL on atherosclerosis by regulating cell proliferation and apoptosis[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 113-117.
[15] WANG Shiying,GU Xinhua. Progress on clinical application of orthodontic-implant combined therapy[J]. J Zhejiang Univ (Med Sci), 2020, 49(1): 124-130.